Inhibition of insulin fibrillation by osmolytes: Mechanistic Insights

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Choudhary, Sinjan ^a   Kishore, Nand ^b   Hosur, Ramakrishna V ^a,c  

^a UM DAE CENTRE FOR EXCELLENCE IN BASIC SCIENCES   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^c TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; BETAINE; INSULIN; PROLINE; PROTEIN BINDING; SORBITOL;

BIOLOGICAL MODEL; CALORIMETRY; CHEMISTRY; KINETICS; METABOLISM; OSMOLARITY; PROTEINOSIS; ULTRASTRUCTURE;

AMYLOID; BETAINE; CALORIMETRY; INSULIN; KINETICS; MODELS, BIOLOGICAL; OSMOLAR CONCENTRATION; PROLINE; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN BINDING; SORBITOL;

EID: 84948807964     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17599     Document Type: Article

References (124)

1. Chiti, F. & Dobson, C. M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem.75, 333-366 (2006).
2. Herczenik, E. & Gebbink, M. F. Molecular and cellular aspects of protein misfolding and disease. FASEB J. 22, 2115-2133 (2008).
3. Sunde, M. et al. The common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Bio. 273, 729-739 (1997).
4. McLaurin, J., Kierstead, M. & Fraser, P. Anti-beta amyloid aggregation therapy. Neurobiol. Aging, 23, 1580-1586 (2002).
5. Uversky, V. N. & Eliezer, D. Biophysics of Parkinsons disease: structure and aggregation of alpha-synuclein. Curr. Prot. Pept. Sci. 5, 483-499 (2009).
6. Tjernberg, L. O. et al. Arrest of beta-amyloid fibril formation by apenta peptide ligand. J. Biol. Chem. 271, 8545-8548 (1996).
7. Conway, K. A., Rochet, J. C., Bieganski, R. M. & Lansbury, P. T. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294, 1346-1349 (2001).
8. Davis-Searles, P. R. et al. Interpreting the effects of small uncharged solutes on protein- folding equilibria. Ann. Rev. Biophys. Biomol. Struct. 30, 271-306 (2001).
9. Ebel, C., Eisenberg, H. & Ghirlando, R. Probing protein- sugar interactions. Biophys J. 78, 385-393 (2000).
10. Wendorf, J. R., Radke, C. J. & Blanch, H. W. Reduced protein adsorption at solid interfaces by sugar excipients. Biotechnol. Bioeng. 87, 565-573 (2004).
11. Bolen, D. W. Protein stabilization by naturally occurring osmolytes. Methods Mol. Biol. 168, 17-36 (2001).
12. Rosgen, J., Pettitt, B. M. & Bolen, D. W. An analysis of the molecular origin of osmolytes-dependent protein stability. Prot. Sci.16, 733-743 (2007).
13. Timasheff, S. N. Control of protein stability and reactions by weakly interacting cosolvents: the simplicity of the complicated. Adv. Protein Chem. 51, 355-432 (1998).
14. Kendrick, B. S., Carpenter, J. F., Cleland, J. L. & Randolph, T. W. A transient expansion of the native state precedes aggregation of recombinant human interferon-c. Proc. Natl. Acad. Sci. USA. 95, 14142-14146 (1998).
15. Bhavsar, R. D., Prasad, S. & Roy, I. Effect of osmolytes on the fibrillation of Hyp F-N. Biochimie, 95, 2190-2193 (2013).
16. Olsen,S. N., Ramlov, H. & Westh, P. Effects of osmolytes on hexokinase kinetics combined with macromolecular crowding: Test of the osmolyte compatibility hypothesis towards crowded systems. Comp. Biochem. Phys. A: Mol. Integr. Physiol. 148, 339-345 (2007).
17. Wawer, J. et al. Inhibition of amyloid fibril formation of hen egg white lysozyme by trimethylamine N-oxide at low pH. Int. J. Biol. Macromol. 70, 214-221(2014).
18. Macchi, F., Eisenkolb, M., Kiefer, H. & Otzen, D. E. The Effect of Osmolytes on Protein Fibrillation. Int. J. Mol. Sci. 13, 3801-3819 (2012).
19. Arora, A., Hab, C. & Park, C. B. Inhibition of insulin amyloid formation by small stress molecules. FEBS Lett. 564, 121-125 (2004).
20. Lippert, K. & Galinski, E. A. Enzyme stabilization by ectoine-type compatible solutes: protection against heating, freezing and drying. Appl. Micro. boil. Biotechnol. 37, 61-65(1992).
21. Goller, K. & Galinski, E. A. Protection of a model enzyme (lactate dehydrogenase) against heat, urea and freeze-thaw treatment by compatible solute additive. J. Mol. Catal. B Enzym. 7, 37-45 (1999).
22. Kaushik, J. K. & Bhat, R. Why is trehalose an exceptional protein stabilizer? J. Biol. Chem.278, 26458-26465 (2003).
23. Akashi, K., Miyake, C. & Yokota, A. Citrulline, a novel compatible solute in drought- tolerant wild watermelon leaves, is an efficient hydroxyl radical scavenger. FEBS Lett. 508, 438-442 (2001).
24. Kanapathipillai, M., Ku, S. H., Girigoswami, K. & Park, C. B. Small stress molecules inhibit aggregation and neurotoxicity of prion peptide. Biochem. Biophys. Res. Commun. 365, 106-126 (2008).
25. Kanapathipillaia, M., Lentzenb, G., Sierksa, M. & Park, C. B. Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimers β-amyloid. FEBS Lett. 579, 4775-4780 (2005).
26. Lee, J. & Pilch, P. F. The insulin receptor: structure, function and signalling. Am. J. Physiol. 266, C319-C334 (1994).
27. Burke, M. J. & Rougvie, M. A. Cross-β protein structures.I. Insulin fibrils. Biochemistry 11, 2435-2439 (1972).
28. Nielsen, L. et al. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 40, 6036-6046 (2001).
29. Nettleton, E. J. et al. Characterization of the oligomeric states of insulin in self-assembly and amyloid fibril formation by mass spectrometry. Biophys. J. 79, 1053-1065 (2000).
30. Dodson, G. G. & Steiner, D. The role of assembly in insulins biosynthesis. Curr. Opin. Struct. Biol. 8, 189-194 (1998).
31. Yumlu, S., Barany, R., Eriksson, M. & Rocken, C. Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report. Hum. Pathol. 40, 1655-1660 (2009).
32. Shikama, Y. et al. Localized amyloidosis at the site of repeated insulin injection in a diabetic patient. Intern. Med. 49, 397-401 (2010).
33. Waugh, D. F., Wilhelmson, D. F., Commerford, S. L. & Sackler, M. L. Studies of the Nucleation and Growth Reactions of Selected Types of Insulin Fibrils. J. Am. Chem. Soc. 75, 2592-2600 (1953).
34. Ahmad, A., Uversky, V. N., Hong, D. & Fink, A. L. Early Events in the Fibrillation of Monomeric Insulin. J. Biol. Chem. 280, 42669-42675 (2005).
35. Chiti, F. & Dobson, C. M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem.75, 333-366 (2006).
36. Herczenik, E. & Gebbink, M. F. Molecular and cellular aspects of protein misfolding and disease. FASEB J. 22, 2115-2133 (2008).
37. Sunde, M. et al. The common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Bio. 273, 729-739 (1997).
38. McLaurin, J., Kierstead, M. & Fraser, P. Anti-beta amyloid aggregation therapy. Neurobiol. Aging, 23, 1580-1586 (2002).
39. Uversky, V. N. & Eliezer, D. Biophysics of Parkinsons disease: structure and aggregation of alpha-synuclein. Curr. Prot. Pept. Sci. 5, 483-499 (2009).
40. Tjernberg, L. O. et al. Arrest of beta-amyloid fibril formation by apentapeptide ligand. J. Biol. Chem. 271, 8545-8548 (1996).
41. Conway, K. A., Rochet, J. C., Bieganski, R. M. & Lansbury, P. T. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294, 1346-1349 (2001).
42. Davis-Searles, P. R. et al. Interpreting the effects of small uncharged solutes on protein- folding equilibria. Ann. Rev. Biophys. Biomol. Struct. 30, 271-306 (2001).
43. Ebel, C., Eisenberg, H. & Ghirlando, R. Probing protein- sugar interactions. Biophys J. 78, 385-393 (2000).
44. Wendorf, J. R., Radke, C. J. & Blanch, H. W. Reduced protein adsorption at solid interfaces by sugar excipients. Biotechnol. Bioeng. 87, 565-573 (2004).
45. Bolen, D. W. Protein stabilization by naturally occurring osmolytes. Methods Mol. Biol. 168, 17-36 (2001).
46. Rosgen, J., Pettitt, B. M. & Bolen, D. W. An analysis of the molecular origin of osmolytes-dependent protein stability. Prot. Sci.16, 733-743 (2007).
47. Timasheff, S. N. Control of protein stability and reactions by weakly interacting cosolvents: the simplicity of the complicated. Adv. Protein Chem. 51, 355-432 (1998).
48. Kendrick, B. S., Carpenter, J. F., Cleland, J. L. & Randolph, T. W. A transient expansion of the native state precedes aggregation of recombinant human interferon-c. Proc. Natl. Acad. Sci. USA. 95, 14142-14146 (1998).
49. Bhavsar, R. D., Prasad, S. & Roy, I. Effect of osmolytes on the fibrillation of HypF-N. Biochimie, 95, 2190-2193 (2013).
50. Olsen, S. N., Ramlov, H. & Westh, P. Effects of osmolytes on hexokinase kinetics combined with macromolecular crowding: Test of the osmolyte compatibility hypothesis towards crowded systems. Comp. Biochem. Phys. A: Mol. Integr. Physiol. 148, 339-345 (2007).
51. Wawer, J. et al. Inhibition of amyloid fibril formation of hen egg white lysozyme by trimethylamine N-oxide at low pH. Int. J. Biol. Macromol. 70, 214-221(2014).
52. Macchi, F., Eisenkolb, M., Kiefer, H. & Otzen, D. E. The Effect of Osmolytes on Protein Fibrillation. Int. J. Mol. Sci. 13, 3801-3819 (2012).
53. Arora, A., Hab, C. & Park, C. B. Inhibition of insulin amyloid formation by small stress molecules. FEBS Lett. 564, 121-125 (2004).
54. Lippert, K. & Galinski, E. A. Enzyme stabilization by ectoine-type compatible solutes: protection against heating, freezing and drying. Appl. Micro. boil. Biotechnol. 37, 61-65(1992).
55. Goller, K. & Galinski, E. A. Protection of a model enzyme (lactate dehydrogenase) against heat, urea and freeze-thaw treatment by compatible solute additive. J. Mol. Catal. B Enzym. 7, 37-45 (1999).
56. Kaushik, J. K. & Bhat, R. Why is trehalose an exceptional protein stabilizer? J. Biol. Chem.278, 26458-26465 (2003).
57. Akashi, K., Miyake, C. & Yokota, A. Citrulline, a novel compatible solute in drought- tolerant wild watermelon leaves, is an efficient hydroxyl radical scavenger. FEBS Lett. 508, 438-442 (2001).
58. Kanapathipillai, M., Ku, S. H., Girigoswami, K. & Park, C. B. Small stress molecules inhibit aggregation and neurotoxicity of prion peptide. Biochem. Biophys. Res. Commun. 365, 106-126 (2008).
59. Kanapathipillaia, M., Lentzenb, G., Sierksa, M. & Park, C. B. Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimers β-amyloid. FEBS Lett. 579, 4775-4780 (2005).
60. Lee, J. & Pilch, P. F. The insulin receptor: structure, function and signalling. Am. J. Physiol. 266, C319-C334 (1994).
61. Burke, M. J. & Rougvie, M. A. Cross-β protein structures.I. Insulin fibrils. Biochemistry 11, 2435-2439 (1972).
62. Nielsen, L. et al. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 40, 6036-6046 (2001).
63. Nettleton, E. J. et al. Characterization of the oligomeric states of insulin in self-assembly and amyloid fibril formation by mass spectrometry. Biophys. J. 79, 1053-1065 (2000).
64. Dodson, G. G. & Steiner, D. The role of assembly in insulins biosynthesis. Curr. Opin. Struct. Biol. 8, 189-194 (1998).
65. Yumlu, S., Barany, R., Eriksson, M. & Rocken, C. Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report. Hum. Pathol. 40, 1655-1660 (2009).
66. Shikama, Y. et al. Localized amyloidosis at the site of repeated insulin injection in a diabetic patient. Intern. Med. 49, 397-401 (2010).
67. Waugh, D. F., Wilhelmson, D. F., Commerford, S. L. & Sackler, M. L. Studies of the Nucleation and Growth Reactions of Selected Types of Insulin Fibrils. J. Am. Chem. Soc. 75, 2592-2600 (1953).
68. Ahmad, A., Uversky, V. N., Hong, D. & Fink, A. L. Early Events in the Fibrillation of Monomeric Insulin. J. Biol. Chem. 280, 42669-42675 (2005).
69. Chiti, F. & Dobson, C. M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem.75, 333-366 (2006).
70. Herczenik, E. & Gebbink, M. F. Molecular and cellular aspects of protein misfolding and disease. FASEB J. 22, 2115-2133 (2008).
71. Sunde, M. et al. The common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Bio. 273, 729-739 (1997).
72. McLaurin, J., Kierstead, M. & Fraser, P. Anti-beta amyloid aggregation therapy. Neurobiol. Aging, 23, 1580-1586 (2002).
73. Uversky, V. N. & Eliezer, D. Biophysics of Parkinsons disease: structure and aggregation of alpha-synuclein. Curr. Prot. Pept. Sci. 5, 483-499 (2009).
74. Tjernberg, L. O. et al. Arrest of beta-amyloid fibril formation by apentapeptide ligand. J. Biol. Chem. 271, 8545-8548 (1996).
75. Conway, K. A., Rochet, J. C., Bieganski, R. M. & Lansbury, P. T. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294, 1346-1349 (2001).
76. Davis-Searles, P. R. et al. Interpreting the effects of small uncharged solutes on protein- folding equilibria. Ann. Rev. Biophys. Biomol. Struct. 30, 271-306 (2001).
77. Ebel, C., Eisenberg, H. & Ghirlando, R. Probing protein- sugar interactions. Biophys J. 78, 385-393 (2000).
78. Wendorf, J. R., Radke, C. J. & Blanch, H. W. Reduced protein adsorption at solid interfaces by sugar excipients. Biotechnol. Bioeng. 87, 565-573 (2004).
79. Bolen, D. W. Protein stabilization by naturally occurring osmolytes. Methods Mol. Biol. 168, 17-36 (2001).
80. Rosgen, J., Pettitt, B. M. & Bolen, D. W. An analysis of the molecular origin of osmolytes-dependent protein stability. Prot. Sci.16, 733-743 (2007).
81. Timasheff, S. N. Control of protein stability and reactions by weakly interacting cosolvents: the simplicity of the complicated. Adv. Protein Chem. 51, 355-432 (1998).
82. Kendrick, B. S., Carpenter, J. F., Cleland, J. L. & Randolph, T. W. A transient expansion of the native state precedes aggregation of recombinant human interferon-c. Proc. Natl. Acad. Sci. USA. 95, 14142-14146 (1998).
83. Bhavsar, R. D., Prasad, S. & Roy, I. Effect of osmolytes on the fibrillation of HypF-N. Biochimie, 95, 2190-2193 (2013).
84. Olsen, S. N., Ramlov, H. & Westh, P. Effects of osmolytes on hexokinase kinetics combined with macromolecular crowding: Test of the osmolyte compatibility hypothesis towards crowded systems. Comp. Biochem. Phys. A: Mol. Integr. Physiol. 148, 339-345 (2007).
85. Wawer, J. et al. Inhibition of amyloid fibril formation of hen egg white lysozyme by trimethylamine N-oxide at low pH. Int. J. Biol. Macromol. 70, 214-221(2014).
86. Macchi, F., Eisenkolb, M., Kiefer, H. & Otzen, D. E. The Effect of Osmolytes on Protein Fibrillation. Int. J. Mol. Sci. 13, 3801-3819 (2012).
87. Arora, A., Hab, C. & Park, C. B. Inhibition of insulin amyloid formation by small stress molecules. FEBS Lett. 564, 121-125 (2004).
88. Lippert, K. & Galinski, E. A. Enzyme stabilization by ectoine-type compatible solutes: protection against heating, freezing and drying. Appl. Micro. boil. Biotechnol. 37, 61-65(1992).
89. Goller, K. & Galinski, E. A. Protection of a model enzyme (lactate dehydrogenase) against heat, urea and freeze-thaw treatment by compatible solute additive. J. Mol. Catal. B Enzym. 7, 37-45 (1999).
90. Kaushik, J. K. & Bhat, R. Why is trehalose an exceptional protein stabilizer? J. Biol. Chem.278, 26458-26465 (2003).
91. Akashi, K., Miyake, C. & Yokota, A. Citrulline, a novel compatible solute in drought- tolerant wild watermelon leaves, is an efficient hydroxyl radical scavenger. FEBS Lett. 508, 438-442 (2001).
92. Kanapathipillai, M., Ku, S. H., Girigoswami, K. & Park, C. B. Small stress molecules inhibit aggregation and neurotoxicity of prion peptide. Biochem. Biophys. Res. Commun. 365, 106-126 (2008).
93. Kanapathipillaia, M., Lentzenb, G., Sierksa, M. & Park, C. B. Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimers β-amyloid. FEBS Lett. 579, 4775-4780 (2005).
94. Lee, J. & Pilch, P. F. The insulin receptor: structure, function and signalling. Am. J. Physiol. 266, C319-C334 (1994).
95. Burke, M. J. & Rougvie, M. A. Cross-β protein structures.I. Insulin fibrils. Biochemistry 11, 2435-2439 (1972).
96. Nielsen, L. et al. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 40, 6036-6046 (2001).
97. Nettleton, E. J. et al. Characterization of the oligomeric states of insulin in self-assembly and amyloid fibril formation by mass spectrometry. Biophys. J. 79, 1053-1065 (2000).
98. Dodson, G. G. & Steiner, D. The role of assembly in insulins biosynthesis. Curr. Opin. Struct. Biol. 8, 189-194 (1998).
99. Yumlu, S., Barany, R., Eriksson, M. & Rocken, C. Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report. Hum. Pathol. 40, 1655-1660 (2009).
100. Shikama, Y. et al. Localized amyloidosis at the site of repeated insulin injection in a diabetic patient. Intern. Med. 49, 397-401 (2010).
101. Waugh, D. F., Wilhelmson, D. F., Commerford, S. L. & Sackler, M. L. Studies of the Nucleation and Growth Reactions of Selected Types of Insulin Fibrils. J. Am. Chem. Soc. 75, 2592-2600 (1953).
102. Ahmad, A., Uversky, V. N., Hong, D. & Fink, A. L. Early Events in the Fibrillation of Monomeric Insulin. J. Biol. Chem. 280, 42669-42675 (2005).
103. Tyagi, P. Insulin delivery systems: present trends and the future direction. Indian J. Pharmacol. 34, 379-389 (2002).
104. Pryor, E., Kotarek, J. A., Moss, M. A. & Hestekin, C. N. Monitoring Insulin Aggregation via Capillary Electrophoresis. Int. J. Mol. Sci. 12, 9369-9388 (2011).
105. Zhou, X. et al. Hierarchical ordering of amyloid fibrils on the mica surface. Nanoscale 5, 4816-4822 (2013).
106. Ahmad, A., Millett, I. S., Doniach, S., Uversky, V. N. & Fink, A. L. Partially Folded Intermediates in Insulin Fibrillation. Biochemistry 42, 11404-11416 (2003).
107. Bekard, I. B. & Dunstan, D. E. Tyrosine Autofluorescence as a Measure of Bovine Insulin Fibrillation. Biophys. J. 97, 2521-2531 (2009).
108. Muzaffar, M. & Ahmad, A. The Mechanism of Enhanced Insulin Amyloid Fibril Formation by NaCl Is Better Explained by a Conformational Change Model. PloS One 6, e27906 (2011).
109. Wild, S. et al. Global prevalence of diabetes: estimates for 2000 and projections for 2030. Diabetes Care 27, 1047-1053 (2004).
110. Gibson, T. J. & Murphy, R. M. Inhibition of insulin fibrillogenesis with targeted peptides. Prot. Sci.15, 1133-1141 (2006).
111. Giger, K., Vanam, R. P., Seyrek, E. & Dubin, P. L. Suppression of Insulin Aggregation by Heparin. Biomacromolecules 9, 2338-2344 (2008).
112. Malik, R. & Roy, I. Stabilization of bovine insulin against agitation-induced aggregation using RNA aptamers. Int. J. Pharm. 452, 257-265 (2013).
113. Nayak, A., Lee, C. C., McRae, G. J. & Belfort, G. Osmolyte Controlled Fibrillation Kinetics of Insulin: New Insight into Fibrillation Using the Preferential Exclusion Principle. Biotechnol. Prog. 25, 1508-1514 (2009).
114. Gong, H. et al. Effects of several quinones on insulin aggregation. Sci. Rep. 4, 5648 (2014).
115. Levine, H. Thioflavin T interaction with synthetic Alzheimers disease β amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci. 2, 404-410 (1993).
116. Zako, T. et al. Bovine Insulin Filaments Induced by Reducing Disulfide Bonds Show a Different Morphology, Secondary Structure, and Cell Toxicity from Intact Insulin Amyloid Fibrils. Biophys. J. 96, 3331-3340 (2009).
117. Bouchard, M. et al. Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci. 9, 1960-1967 (2000).
118. Choudhary, S. & Kishore, N. Addressing Mechanism of Fibrillization/Aggregation and Its Prevention in Presence of Osmolytes: Spectroscopic and Calorimetric Approach. PloS One 9, e104600 (2014).
119. Arakawa,. T. & Timasheff, S. N. The stabilization of proteins by osmolytes. Biophys. J. 47, 411-414 (1985).
120. Kumar, T. K. S. et al. The role of L-proline in the prevention of aggregation during protein folding in vitro. Biochem. Mol. Biol. Int. 46, 509-517 (1998).
121. Porter, R. R. Partition Chromatography of Insulin and Other Proteins. Biochem. 53, 320-328 (1953).
122. Wall, J., Murphy, C., L. & Solomon, A. In vitro immunoglobulin light chain fibrillogenesis. Methods Enzymol. 309, 204-217 (1999a).
123. Nielsen, L. et al. Effect of Environmental Factors on the Kinetics of Insulin Fibril Formation: Elucidation of the Molecular Mechanism. Biochemistry 40, 6036-6046 (2001).
124. Ohi, M., Li, Y., Cheng, Y. & Walz, T. Negative Staining and Image Classification -Powerful Tools in Modern Electron Microscopy. Biol. Proced. 6, 23-34 (2004).